NCT07388472

Brief Summary

This study aimed to comparatively evaluate the 24-month clinical retention performance and caries-preventive efficacy of three glass ionomer-based fissure sealants with different compositions.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
200

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Nov 2016

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 1, 2016

Completed
2.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2019

Completed
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2020

Completed
6.1 years until next milestone

First Submitted

Initial submission to the registry

January 23, 2026

Completed
13 days until next milestone

First Posted

Study publicly available on registry

February 5, 2026

Completed
Last Updated

February 5, 2026

Status Verified

January 1, 2026

Enrollment Period

2.7 years

First QC Date

January 23, 2026

Last Update Submit

January 30, 2026

Conditions

Keywords

cariespreventionglass ionomer materialfissure sealant

Outcome Measures

Primary Outcomes (1)

  • retention rates of fissure sealants

    Following classification system was employed for the retention evaluation of the sealants: 1 = complete retention; 2 = partial loss; or 3 = complete loss.

    The evaluation of pit-and-fissure sealants was conducted to record the presence of caries lesions and sealant retention at 6-, 12-, 18-, and 24 month follow-up visits.

Study Arms (2)

CPP-ACP-containing fissure sealant

EXPERIMENTAL

In this group, one mandibular molar was treated with a high-fluoride glass ionomer-based fissure sealant (Fuji Triage, GC Corporation, Tokyo, Japan; control group), while the contralateral molar was treated with a CPP-ACP-containing fissure sealant (Fuji VII EP, GC Corporation, Tokyo, Japan)

Other: Retention of Fissure Sealants

Nano-fluorohydroxyapatite-containing fissure sealant

EXPERIMENTAL

In this group, one mandibular molar was treated with a high-fluoride glass ionomer-based fissure sealant (Fuji Triage, GC Corporation, Tokyo, Japan; control group), while the contralateral molar was treated with nano-fluorohydroxyapatite-containing fissure sealant (GCP Glass Seal, GCP Dental, Vianen, The Netherlands)

Other: Retention of Fissure Sealants

Interventions

Other: Retention of the fissure sealants evaluated Description: Following classification system was employed for the retention evaluation of the sealants: 1 = complete retention; 2 = partial loss; or 3 = complete loss.

CPP-ACP-containing fissure sealantNano-fluorohydroxyapatite-containing fissure sealant

Eligibility Criteria

Age6 Years - 12 Years
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17)

You may qualify if:

  • The study comprised 200 healthy children aged between 6 and 12 years, ASA class I (American Society of Anesthesiologists),
  • who were determined to exhibit cooperative behavior with a score of 3 or 4 on the Frankl Behavior Rating Scale.
  • All participants had fully erupted lower first permanent molars on both sides which required the application of pit and fissure sealants.
  • The teeth were examined using the caries diagnosis device (DIAGNOdent pen 2190, KaVo, USA); readings of ≤ 15 were included in the study as well.

You may not qualify if:

  • Participants with special needs or systemic disease (ASA classification II or higher),
  • requiring emergency dental care,
  • suffering from a severe gag reflex or
  • an allergy to latex,
  • exhibiting uncooperative behavior (Frankl Score 1 or 2),
  • exhibiting molars with anomalies of the enamel/dentin, or
  • unable to attend follow-up appointments were excluded from the study.
  • A bitewing radiograph was used to assess teeth suspected of having caries on their proximal surfaces, and those with caries were excluded from the study.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Izmir Katip Celebi University

Izmir, 35640, Turkey (Türkiye)

Location

Study Officials

  • EBRU KUCUKYİLMAZ, PROFESSOR

    İZMİR KATIP CELEBI UNİVERSİTY

    STUDY CHAIR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Masking Details
The study was carried out as a double-blinded trial, whereby neither the patients nor the clinical evaluator was aware of what material was applied to each tooth. No blinding was done during the treatment period because all treatments were performed by one dentist. The randomization process was applied with two phases to ensure unbiased allocation of the fissure sealant materials to the participants. In the first phase of the randomization, which material groups (GC Fuji Triage -GCP Glass Seal/GC Fuji Triage-GC Fuji VII EP) would be applied to each patient was determined using a computer-generated randomization online tool (htpp//randomizer.org). In the second phase of the randomization, the allocation of the material to either the left or right mandibular molar of each participant was established through the coin toss method (heads or tails), and the opposing molar tooth was treated with the other material in accordance with the group designated by the first randomization.
Purpose
PREVENTION
Intervention Model
PARALLEL
Model Details: randomized, controlled, double-blind, split-mouth design A total of 400 sealants were applied to the two fully erupted mandibular first molars of each participant. Following randomization, one molar received GC Fuji Triage (high-fluoride containing/control), while the contralateral molar received either GC Fuji VII EP (CPP-ACP-containing) or GCP Glass Seal (nano-fluorohydroxyapatite-containing).
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Prof. Dr.

Study Record Dates

First Submitted

January 23, 2026

First Posted

February 5, 2026

Study Start

November 1, 2016

Primary Completion

July 1, 2019

Study Completion

January 1, 2020

Last Updated

February 5, 2026

Record last verified: 2026-01

Data Sharing

IPD Sharing
Will share

study plan will be shared

Shared Documents
STUDY PROTOCOL
Time Frame
The plan will be shared following the completion of the research paper (approximately 1 month)
Access Criteria
De-identified individual participant data (IPD) will be made available upon reasonable request following publication of the main results, in accordance with institutional and ethical regulations. Access will be granted to qualified researchers for non-commercial purposes.

Locations